The latest cancer drugs news
Browsing: Cancer Drug News
New approach to cancer research aims to accelerate studies and reduce cost
A new model for improving how clinical trials are developed and conducted by bringing together…
Six months of Herceptin could be as effective as 12 months for some women with HER2 positive breast cancer
For women with HER2 positive early-stage breast cancer taking Herceptin for six months could be…
Scientists identify cause of resistance to breakthrough breast and ovarian cancer drug
Scientists have identified a mutation that gives cancer cells resistance to the breakthrough cancer treatment…
Vinblastine pathways uncovered in Madagascar periwinkle
Plant scientists have taken the crucial last steps in a 60-year quest to unravel the…
Multiple sclerosis drug could reduce painful side effects of common cancer treatment
Researchers from the Saint Louis University School of Medicine have discovered why many multiple myeloma…
Daily aspirin linked to higher skin cancer risk in men
Men who take once-daily aspirin have nearly double the risk of melanoma compared to men…
AACR 2018: How do melanoma cells survive drug treatment long enough to acquire drug resistance?
Cancer often picks up genetic changes that allow it to resist treatment. But this takes…
AACR 2018: Neoadjuvant nivolumab was safe, yielded pathologic responses in patients with resectable lung cancer
The anti-PD1 immunotherapy nivolumab given prior to surgical resection of stage 1-3 non-small cell lung…
AACR 2018: CheckMate-227 meets co-primary endpoint of PFS in NSCLC
Among patients with newly diagnosed advanced non-small cell lung cancer (NSCLC) with high tumour mutational…
AACR 2018: Crizotinib yielded a high objective response rate for adult patients with ALK-positive inflammatory myofibroblastic tumour
Among patients with inoperable, advanced, or metastatic ALK-positive inflammatory myofibroblastic tumour, 50 percent were confirmed…